These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8876160)

  • 21. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
    Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E
    Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.
    Cherry E; Liang C; Rong L; Quan Y; Inouye P; Li X; Morin N; Kotler M; Wainberg MA
    J Mol Biol; 1998 Nov; 284(1):43-56. PubMed ID: 9811541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease.
    Hutoran M; Britan E; Baraz L; Blumenzweig I; Steinitz M; Kotler M
    Virology; 2004 Dec; 330(1):261-70. PubMed ID: 15527851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1.8A X-ray structure of C95M/C1095F double mutant of tethered HIV-1 protease dimer complexed with acetyl pepstatin.
    Prashar V; Hosur MV
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1229-35. PubMed ID: 15451428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.
    Morin N; Cherry E; Li X; Wainberg MA
    J Hum Virol; 1998; 1(3):240-7. PubMed ID: 10195247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation.
    Babé LM; Craik CS
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2430-9. PubMed ID: 7840583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases.
    Babé LM; Rosé J; Craik CS
    Protein Sci; 1992 Oct; 1(10):1244-53. PubMed ID: 1338945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenesis of the dimer interface residues of tethered and untethered HIV-1 protease result in differential activity and suggest multiple mechanisms of compensation.
    Choudhury S; Everitt L; Pettit SC; Kaplan AH
    Virology; 2003 Mar; 307(2):204-12. PubMed ID: 12667791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Single Amino Acid Substitution at the HIV-1 Protease Termini Dimer Interface Significantly Reduces Viral Particles Processing Efficiency.
    Chiang M; Wang C
    Jpn J Infect Dis; 2021 Jul; 74(4):299-306. PubMed ID: 33390426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
    Louis JM; Clore GM; Gronenborn AM
    Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays.
    Robinson LH; Myers RE; Snowden BW; Tisdale M; Blair ED
    AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1149-56. PubMed ID: 10954890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV protease activity by heterodimer formation.
    Babé LM; Pichuantes S; Craik CS
    Biochemistry; 1991 Jan; 30(1):106-11. PubMed ID: 1988010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
    Mulky A; Vu BC; Conway JA; Hughes SH; Kappes JC
    J Mol Biol; 2007 Feb; 365(5):1368-78. PubMed ID: 17141805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations.
    Levy Y; Caflisch A; Onuchic JN; Wolynes PG
    J Mol Biol; 2004 Jun; 340(1):67-79. PubMed ID: 15184023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach.
    Davis DA; Tebbs IR; Daniels SI; Stahl SJ; Kaufman JD; Wingfield P; Bowman MJ; Chmielewski J; Yarchoan R
    Biochem J; 2009 Apr; 419(2):497-506. PubMed ID: 19149765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
    Towler EM; Gulnik SV; Bhat TN; Xie D; Gustschina E; Sumpter TR; Robertson N; Jones C; Sauter M; Mueller-Lantzsch N; Debouck C; Erickson JW
    Biochemistry; 1998 Dec; 37(49):17137-44. PubMed ID: 9860826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered replicative capacity of recombinant HIV type 1 containing mutations at codons 26 and 29 of the viral protease.
    Melón S; Gil-Roda C; de Oña M; Erice A
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1183-8. PubMed ID: 15588340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.